NCDHHS Partners with Talkspace to Provide Free Virtual Mental Health Therapy to Teens Involved in or Impacted By the Justice System
The North Carolina Department of Health and Human Services today announced a first-of-its-kind partnership with Talkspace, a virtual therapy platform now available for free to justice-impacted teenagers between the ages of 13 and 17 in North Carolina.
Recent data from North Carolina shows that 100% of young people in youth development centers had at least one mental health diagnosis, with more than half also having a substance use disorder diagnosis. Additionally, youth involvement in the justice system can increase a young person's risk of experiencing more trauma or psychological distress. It can also lead to increased risk of adult criminal activity, lower education attainment and difficulty finding a job.
'There is an urgent need for youth-focused solutions to help young people involved in the justice system get the care they need so they can thrive in their homes and communities,' said NC Health and Human Services Secretary Dev Sangvai. 'The partnership with Talkspace is one of the ways the department is working to transform mental health care to build a system that works for every person in North Carolina.'
The Talkspace partnership is a part of an effort to expand services for individuals in the justice system, with a focus on increasing quality and consistency of behavioral health programs for youth. The two-year program will serve as many as 20,000 youth impacted by the legal system, including people who may have personally been detained/court-involved, have lived experience as victims of crime or are otherwise identified as at risk (for example, having incarcerated members of family).
Teenagers who download the app or go to the website will be put in contact with a trained clinician who can be matched by age, culture, gender, etc. The platform offers 24/7 text, audio and video access and self-guided activities. Those participating may immediately access Talkspace services using a referral keyword provided by court counselors, case managers or other community partners such as local Juvenile Crime Prevention Councils and other youth advocacy groups. Participation is voluntary and will not be court-ordered.
Talkspace offers 'asynchronous' therapy which differs from traditional approaches by allowing therapists and clients to communicate in various formats without scheduled appointments. The client engages in the therapeutic process whenever and wherever is most convenient.
'Increasing access to treatment is critical for justice-involved youth. Tele-mental health does this by meeting youth and families where they are and allows for immediate therapy from culturally responsive providers in a comfortable format,' said Kelly Crosbie MSW, LCSW, NCDHHS Director of the Division of Mental Health, Developmental Disabilities and Substance Use Services. 'Ensuring children and youth involved with or impacted by the justice system receive mental health care is critical in stopping the re-entry cycle and ensuring children go on to live full and meaningful lives.'
'We're proud to partner with the North Carolina Juvenile Justice System and NCDHHS to bring accessible, confidential mental health support to teens who need it most,' said Jon Cohen, M.D., Chief Executive Officer at Talkspace. 'This collaboration marks a meaningful expansion of our work with youth—reaching them in a new context, at a critical moment, and reinforcing our commitment to equitable care for all.'
This initiative is part of NCDHHS' mission to improve access to mental health care in North Carolina and is funded by the $835 million investment that focuses on mental health transformation. An overview of the historic investment made possible by the NC General Assembly is available in this white paper: Transforming North Carolina's Behavioral Health System; Investing in a system that delivers whole-person care when and where people need it.
About Talkspace
Talkspace is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+).
For more information, visit www.talkspace.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250730294930/en/
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA NORTH CAROLINA
INDUSTRY KEYWORD: HEALTH MENTAL HEALTH TELEMEDICINE/VIRTUAL MEDICINE
SOURCE: Talkspace
Copyright Business Wire 2025.
PUB: 07/30/2025 02:30 PM/DISC: 07/30/2025 02:31 PM
http://www.businesswire.com/news/home/20250730294930/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
IDF reservists seeking trauma treatment up 1000%, unit cmdr. tells 'Post'
The amount of reservists seeking treatment for trauma jumped from 270 per year to around 3,000, according to IDF Lt.-Col. Uzi Bechor. The volume of reservists seeking treatment for trauma has jumped from 270 per year to around 3,000, a jump of more than 1,000%, Lt.-Col. Uzi Bechor, head of the Combat Mental Health Unit for reservist soldiers, has told The Jerusalem Post. Bechor's unit is ready to help any soldier experiencing trauma, whether due to post-traumatic stress disorder, general depression, or physical symptoms, such as shaking. Explaining the difference between his unit and other arms of the IDF and the Defense Ministry that handle trauma-related issues for soldiers, he said, 'We do not deal with active soldiers. We deal with discharged or reservist soldiers who are now civilians. This is an unusual situation compared to the rest of the world. 'In 1982 [following the First Lebanon War], we took responsibility for those in the hardest situations, even after their discharge, so they would get the most professional mental and emotional treatment within the IDF,' said Bechor. 'Someone comes to us, and there is no bureaucracy. They get a quick initial evaluation, and then we can immediately offer them individualized treatment. There are many different types of treatment." 'There has been a huge increase in treatment since the start of the war. But we were also on the way to being prepared for this as the war started,' he noted. Distinguishing between his unit and the Defense Ministry, he said, 'We give quality care. We give treatment, not financial support rights. But just addressing trauma does not need all of these bureaucratic processes.' Using Bechor's services does not restrict applying to the Defense Ministry for seeking financial support rights. There are soldiers who receive support from both. For Bechor's unit, the evaluation determines how long their treatment should be. Many soldiers who receive treatment will get between 12 to 15 psychological treatment sessions, while others may receive a full year or more of such sessions. However, the treatment Bechor's unit provides is not lifelong, so in cases where lifelong treatment is needed, his unit will even recommend coverage to the Defense Ministry. Treatment also offered to combat support soldiers, incl. medics, drivers The treatment is offered not only to combat fighters, but also to combat-support soldiers, including medics and drivers. There is also a special provision for the unit to provide treatment to desk-job soldiers who were impacted by Hamas's October 7 massacre. In essence, Bechor said his unit is 'concerned about the substance of the trauma's impact on soldiers' ability to function, not bureaucratic formalities.' He said his team has multidisciplinary expertise: from clinical psychologists to social workers to therapists to psychiatrists. His unit includes a mix of mandatory service-trained care providers and reservist care providers, all relating to assisting with trauma. In addition, his unit is open to creative therapies like music therapy, as long as there is a proven track record for such therapies. 'Previously, we dealt with 270 patients per year. Since the war, this has increased dramatically to 3,000.' Part of this, he said, is the increased trauma from such a long and intense war, but some of it is that soldiers are shifting to being more ready to seek treatment earlier on after experiencing trauma. He said some soldiers have even called in from the battle zone in Gaza to set up appointments for after their release from active duty. According to Bechor, the average time for soldiers to seek treatment after a traumatic event used to be 10 years. Today, he said the average time is closer to one to two weeks. In the past, he said, there were commanders who delegitimized receiving treatment. However, after years of social campaigns on the issue, he said most commanders and soldiers now view receiving treatment for trauma as a normal aspect of many soldiers' service. His staff now includes up to 800 reservists who can provide treatment also in more peripheral parts of the country. Bechor was questioned about allegations that both operational commanders and IDF health professionals emphasize sending soldiers back to the front as a self-evident standard of success instead of looking at the question of whether a traumatized soldier should return to combat. He responded, arguing that there are academic studies that say that patients recover from certain categories of trauma better if they return to their normal activities, including soldiers. Further, he cited studies stating that many of those traumatized by the Yom Kippur War were pulled out of military service and that many of them fared more poorly than those who returned to service. Such conclusions are hard to prove, given that who returns and does not return to service can also be self-selecting and self-confirming of one view or another, but they are still serious arguments to contend with. Next, he was pressed further about whether returning traumatized soldiers to combat in a much longer war, like the current one, where there is an increased chance of cumulative trauma, is still a wise move, especially in light of an escalating suicide rate for reservists. He responded, recognizing the unique nature of the current extra-long war and its impact on the suicide rate. 'We have to do our best in this very complex situation. We need to carry out treatment mid-war and be on guard for symptoms of being under desperate stress, which increases the rate of suicide,' he said. 'Most of the soldiers who took their lives had not been identified by the military therapists or other parts of the health care system. In contrast, when someone in danger of potential suicide comes to a professional, we can deal with it. This is why we talk to the media, to increase awareness,' stated Bechor. He also noted there is an emergency 24/7 hotline, *6990, followed by the #4, to call for military therapists if a soldier needs immediate help and cannot wait for a business hours appointment. Bechor was also asked about the recent high-profile court martial of Givati soldiers who had served over 300 days through traumas and were almost thrown in military jail when they requested to be reassigned to desk jobs instead of serving in Gaza because of their emotional trauma. Being unable to address the specific case, he responded to the general problem, saying, 'Commanders are not perfect. We are not 100% right, now. We have lost commanders and soldiers, and we see burnout. The commanders are speaking about this more openly – encouraging people to seek treatment and demonstrating by personal example. 'These are processes that did not happen in the past. Five years ago, many soldiers were embarrassed if they spoke to an army therapist or psychologist for treatment,' he added. 'Now it is completely different, and it is not just because there is a more significant burden on soldiers due to the longer war. There are also deeper changes in Israel and in the IDF socially. I see this every day. We get calls all the time. We are always asking how we can do better. And every episode needs to be reviewed.' Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
eHealth (EHTH) Q2 Earnings Report Preview: What To Look For
Online health insurance comparison site eHealth (NASDAQ:EHTH) will be reporting results this Wednesday morning. Here's what to expect. eHealth beat analysts' revenue expectations by 13.4% last quarter, reporting revenues of $113.1 million, up 21.7% year on year. It was an exceptional quarter for the company, with a solid beat of analysts' EBITDA estimates and full-year EBITDA guidance exceeding analysts' expectations. It reported 1.16 million users, down 1.8% year on year. Is eHealth a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting eHealth's revenue to decline 29.5% year on year to $46.41 million, a further deceleration from the 1.4% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$1.25 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. eHealth has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 13.1% on average. Looking at eHealth's peers in the online marketplace segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Shutterstock delivered year-on-year revenue growth of 21.3%, beating analysts' expectations by 7.5%, and EverQuote reported revenues up 33.7%, in line with consensus estimates. Shutterstock's stock price was unchanged following the results. Read our full analysis of Shutterstock's results here and EverQuote's results here. Investors in the online marketplace segment have had steady hands going into earnings, with share prices up 1.5% on average over the last month. eHealth is down 22.5% during the same time and is heading into earnings with an average analyst price target of $10 (compared to the current share price of $3.21). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution
At-home participation in a study by Scripps Research and Schmidt Initiative for Long Covid powered by CareEvolution's MyDataHelps® platform ANN ARBOR, Mich., August 05, 2025--(BUSINESS WIRE)--Long Covid patients around the U.S. looking to participate in a clinical trial from home can sign up to be notified when an upcoming study conducted by scientists at Scripps Research and supported by the Schmidt Initiative for Long Covid (SILC) opens. Patients can sign up on the Long Covid Treatment Trial (LoCITT) website. The upcoming study, powered by the MyDataHelps platform from CareEvolution, is a fully remote clinical trial investigating the efficacy of a repurposed drug for treating Long COVID. It will enroll 1,000 Long Covid patients from across the U.S. The app-based study enables participants to enroll and participate in all trial activities without having to visit a trial clinic. "Decentralized trials broaden reach, speed timelines and yield richer real-world evidence," said Vik Kheterpal, MD, a principal at CareEvolution. "LoCITT will help advance how efficiently we can run trials as we seek treatments for complex, heterogeneous conditions like Long Covid." Long Covid, which has affected the lives of 400 million people worldwide and costs the global economy an estimated $1 trillion per year, can often cause symptoms that make mobility and travel challenging for patients who want to participate in trials. The forthcoming Scripps Research-led trial will rely on the LoCITT platform to enroll patients, distribute drug candidates and placebos, as well as collect and evaluate trial data. "For people with severe Long Covid, travel can be dangerous," said Julia Moore Vogel, senior program director at the Scripps Research Translational Institute. "LoCITT enables even patients with the most severe symptoms to join the search for answers." Moore Vogel is co-principal investigator of the study alongside Scripps Research executive vice president Eric Topol. Remote trials, which eliminate the need for patients to report to clinics, enable easier and broader participation. Conducting a Long Covid trial remotely will also allow more representative cohorts—potentially leading to more generalizable findings. "We need aggressive, rapid efforts to turn the tide on this very difficult condition for all the patients who struggle with it," said John Redd, CEO of SILC. "We're hopeful that a remote trial will help us find effective treatments more quickly." CareEvolution adapted its existing MyDataHelps decentralized clinical trial platform specifically for the LoCITT trial, with the potential for it to be used by other research efforts. The platform will allow for patients to be screened, enrolled and randomized more swiftly. Potential treatments and placebos will be mailed directly to the participant's home, along with wearable devices and other technologies to collect patient data. CareEvolution's user-friendly platform allows patients to check their eligibility, provide consent electronically and respond to baseline and ongoing surveys about their symptoms. Patients selected for the study will receive wrist devices to monitor their heart rates, activity and sleep, potentially enabling the development of digital biomarkers for Long Covid and related conditions like myalgic encephalomyelitis (ME), which can cause debilitating fatigue, and postural orthostatic tachycardia syndrome (POTS), which can cause dizziness, fatigue and a rapid heart rate upon standing up. The data from the devices will be uploaded to LoCITT. Prospective participants who are 18 years of age or older and who believe they have Long Covid can sign up at to be notified when the Scripps clinical trial opens. About CareEvolution We Connect Healthcare. MyDataHelps®, our digital clinical trials platform, accelerates healthcare innovation by empowering researchers to configure and launch studies in hours. We enable anyone, anywhere to be able to participate in research using participant centric design that integrates surveys, wearable and sensor data, EHR connectivity, and participant engagement tools to generate robust real-world longitudinal data. Trusted by over 2.5 million participants enrolled in longitudinal initiatives sponsored by health systems, academic institutions, life science companies, foundations, and public health agencies, CareEvolution advances precision health and helps close critical gaps in our collective understanding of complex conditions. For more information please visit About the Schmidt Initiative for Long Covid The Schmidt Initiative for Long Covid (SILC) advances clinical care for Long Covid patients globally. The nonprofit organization, founded in 2023 by philanthropists Eric and Wendy Schmidt, works to raise the level of Long Covid care and understanding around the world, connecting specialists and primary care providers to support patients and share knowledge virtually, in real time. For more information, visit About Scripps Research Scripps Research is an independent, nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation by Nature Index. We are advancing human health through profound discoveries that address pressing medical concerns around the globe. Our drug discovery and development division, Calibr-Skaggs, works hand-in-hand with scientists across disciplines to bring new medicines to patients as quickly and efficiently as possible, while teams at Scripps Research Translational Institute harness genomics, digital medicine and cutting-edge informatics to understand individual health and render more effective healthcare. Scripps Research also trains the next generation of leading scientists at our Skaggs Graduate School, consistently named among the top 10 US programs for chemistry and biological sciences. Learn more at View source version on Contacts CareEvolutionpr@ Swati Pandey, SILCspandey@ Anna Andersen, Scripps Researchaanders@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
